¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mass treatment"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mass miniature radiography
    Áý´Ü°£Á¢¹æ»ç¼±ÃÔ¿µ(¼ú), X¼±Áý´Ü°£Á¢°ËÁø
  • mass polymerization
    µ¢ÀÌÁßÇÕ
  • mass radiography
    Áý´Ü¹æ»ç¼±ÃÔ¿µ(¼ú), X¼±Áý´Ü°ËÁø
  • mass reflex
    Áý´Ü¹Ý»ç
  • mass screening
    Áý´Ü¼±º°°Ë»ç
  • mass spectrograph
    Áú·®ºÐ±¤»çÁø±â, Áú·®ºÐ¼®±â
  • mass spectrography
    Áú·®ºÐ±¤ºÐ¼®(¹ý)
  • mass spectrometer
    Áú·®ºÐ±¤°è
  • polypoid mass
    Æú¸³¸ð¾çµ¢ÀÌ, Æú¸³¸ð¾çÁ¾±«
  • sonolucent mass
    ÃÊÀ½ÆÄÅõ°úÁ¾±«
  • selective mass chemotherapy
    ¼±ÅÃÁý´ÜÈ­Çпä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • effective mass
    À¯È¿Áú·®
  • electronic mass
    ÀüÀÚÁú·®
  • embryonic mass
    ¹è¾Æµ¢ÀÌ
  • equivalent mass
    µî°¡Áú·®
  • mass effect
    µ¢ÀÌÈ¿°ú
  • mass epidemic
    Áý´ÜÀ¯Çà
  • mass examination
    Áý´Ü°ËÁø, Áý´Ü°Ë»ç
  • germinal mass
    ¹è¼¼Æ÷±º
  • gravitational mass
    Áß·ÂÁú·®
  • inner cell mass
    ¼Ó¼¼Æ÷µ¢ÀÌ
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ
  • mass infection
    Áý´Ü°¨¿°
  • lateral mass
    °¡Âʵ¢ÀÌ
  • lean body mass
    ¸¶¸¥Ã¼Áß, Á¦Áö¹æÃ¼Áß
  • mass lesion
    µ¢À̺´ÅÍ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mass radiography
    X¼±Áý´Ü°ËÁø(ÊÙËṲ̂ËÀ˧̤).
  • mass radiography apparatus
    Áý´Ü ¹æ»ç¼±ÃÔ¿µÀåÄ¡
  • mass radiography apparatus
    Áý´Ü°ËÁø¿ë X¼±ÀåÄ¡(̤ËÀ˧̤ËíÊÙËÛËö̬).
  • mass reflex
    ÁýÇչݻç(ó¢ùêÚãÞÒ).
  • mass scattering power
    Áú·®»ê¶õ´É
  • mass spectrograph
    Áú·®ºÐ±¤±â.
  • mass spectrography
    Áú·®ºÐ±¤°èÃø¹ý.
  • mass spectrometer
    Áú·®ºÐ±¤°è(¡­ÝÂÎÃͪ).
  • mass spectroscopy with gas
    °¡½ºÁú·®ÃøÁ¤¹ý
  • mass stopping power
    Áú·®ÀúÁö´É
  • mass susceptibility
    Áú·® ¹Î°¨µµ
  • mass vaccination
    Áý´Ü(¿¹¹æ)Á¢Á¾(ó¢Ó¥çãÛÁïÈðú).
  • mass vaccination
    Áý´Ü(¿¹¹æ)Á¢Á¾(̤ËÀËçËÑËøÌ¡).
  • mercury mass
    ¼öÀº¿¬Á¦(¡­æèð¥).
  • minature(mass) radiography
    ¹æ»ç Áý´Ü°£Á¢ÃÔ¿µ¼ú(̤ËÀË§ËøÌ§ËçËà).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
EVM electronic voltmeter; extravascular mass
FFM fat-free mass; fundus flavimaculatus
FM face mask; facilities management; family medicine; feedback mechanism; fetal movement; fibromuscular...
GC-MS gas chromatography-mass spectrometry
GLC-MS gas-liquid chromatography-mass spectrometry
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
IOTN Index of Orthodontics Treatment Need
MMT Methadone Maintenance Treatment
MMTP Methadone Maintenance Treatment Program
NT No Treatment
NCCTG North Central Cancer Treatment Group
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rights to choose treatment
    Ä¡·á ¼±ÅñÇ
  • root canal treatment
    ±Ù°ü Ä¡·á
    ¹ß¼ö¿Í Á¼Àº ¶æÀÇ ±Ù°ü Ä¡·áÀÎ °¨¿° ±Ù°ü Ä¡·á
  • shock treatment
    ¼ï Ä¡·á
    Ä«¸£µð¾ÆÁ¹ °æ·Ã ¿ä¹ý, Àü±â ¼îÅ© ¿ä¹ý, Àν¶¸° ¼îÅ© ¿ä¹ý µîÀÌ ÀÖ´Ù.
  • slush treatment : ÁÂâÀÇ Ä¡·á¹ýÀ¸·Î¼­, ¼³»ó ÀÌ»êȭź¼Ò, ¾Æ¼¼Åæ, ȲÀÇ ÇÕÁ¦¸¦ »ç¿ëÇÏ´Â ¿ä¹ý.

    SMAF

    ƯÀÌ ´ë½Ä¼¼Æ÷ ¹«ÀåÈ­ ÀÎÀÚ
  • softening heat-treatment
    ¿¬È­ ¿­ ó¸®
    ±Ý¼Ó ¹× ÇÕ±Ý Àç·á´Â °¡°øÇÏ¸é ¿Ö°î ¶§¹®¿¡ ±»¾îÁø´Ù. ÀÌ °°Àº Àç·á¿¡ °¡°ø¼ºÀ» ³ôÀ̱â À§Çؼ­ ȤÀº ±âŸ ¿Ö°îÀ» ¿ÏÀüÈ÷ Á¦°ÅÇϱâ À§ÇÏ¿© ÇàÇÏ´Â ¿­ ó¸®.
  • somatic treatment
    ½Åü Ä¡·á
  • treatment appointment
    Ä¡·á¸¦ À§ÇÑ ³»¿ø
  • treatment by perspiration
    ¹ßÇÑ ¿ä¹ý
    ¾àÁ¦³ª ¹°¸®Àû ¹æ¹ý¿¡ ÀÇÇØ ÀΰøÀûÀ¸·Î ¹ßÇѽÃÄÑ Ã¼¿­À» ¹ß»ê, ¶Ç´Â ¹ßÇÑ¿¡ ÀÇÇÑ ¼öºÐ ¹æÃâÀ» ÀÌ¿ëÇÏ¿© ºÎÁ¾À» Á¦°ÅÇÏ´Â ¿ä¹ý. Çѹý, ÇØ¹ýÀ̶ó°íµµ ÇÑ´Ù. Áï, ¹ßÇѽÃÅ´À¸·Î½á ½ÅÁø ´ë»ç »ê¹° ¶Ç´Â ü³»¿¡ ÃàÀûµÈ ÀÌ»ó¹°ÁúÀ» ¹èÁ¦½ÃŰ°Å³ª, ¶§·Î´Â ºñƯÀÌ º¯Á¶ È¿°ú¸¦ ±â´ëÇÏ´Â Ä¡·á¹ýÀÌ´Ù. º¸Åë °¨±âÀÇ Ãʱ⳪ ±Þ¼º »ó±âµµ¿°ÀÇ ¹ß¿­ ½Ã¿¡ ¾Æ½ºÇǸ°, Æä³ª¼¼Æ¾ µîÀÇ ¾àÁ¦¸¦ º¹¿ëÇÏ°í µû¶æÇÑ ¹æ¿¡¼­ ¿ÊÀ» µÎ²®°Ô ÀÔ°í ¶¡À» »©°Ô ÇÏ´Â ¹æ¹ýÀÌ ÈçÈ÷ ¾²À̰í ÀÖ´Ù. ÀÌ ¹Û¿¡ ¿­ÅÁ¿åÀ» ÇÏ´Â °æ¿ìµµ ÀÖÀ¸¸ç, ÀÌ¿Í °°Àº °æ¿ì ¹ßÇÑ ÈÄ¿¡µµ ¸öÀ» °è¼Ó ´þ°Ô À¯ÁöÇÒ Çʿ䰡 ÀÖ´Ù. ½ÉÀå ¼è¾à, Å»¼öÁõ, ÃâÇ÷ °ú´Ù, Áø¾× ¼Õ½Ç µî¿¡´Â À̸¦ ±ÝÇÑ´Ù.
  • treatment field
    Ä¡·á ¹üÀ§
  • treatment of choice
    ÃÖÀû ¿ä¹ý
  • treatment outcome form
    Ä¡·á °á°ú Æò°¡Ç¥
  • treatment planning
    Ä¡·á °èȹ, Ä¡·á °èȹ ¼ö¸³
  • treatment room
    óġ½Ç, Ä¡·á½Ç
  • vibration treatment
    Áøµ¿ ¿ä¹ý
  • virtual treatment
    °¡»ó Ä¡·á
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
adrenal mass <radiology> Metastasis, most common (especially lung, melanoma), primary adenocarcinoma, large at diagnosis (greater than 5 cm), usually functional (increased corticosteroids most likely to be Cushing's), rapid growth, benign adrenal adenoma, with or without functional, nonfunctional occurs in 2-8% of population, diff from metastasis: MRI (metastasis bright on T2), biopsy, follow, pheochromocytoma, neuroblastoma, myelolipoma, cyst / pseudocyst see also: adrenal calcification, haemorrhage
(12 Dec 1998)
apperceptive mass The already existing knowledge base in a similar or related area with which the new perceptual material is articulated.
(05 Mar 2000)
atomic mass <chemistry, physics> The mass of an atom relative to other atoms.
The present-day basis of the scale of atomic weights is carbon, the most common isotope of this element has arbitrarily been assigned an atomic weight of 12.
The unit of the scale is 1/12 the weight of the carbon atom or roughly the mass of one proton or one neutron. The atomic weight of any element is approximately equal to the total number of protons and neutrons in is nucleus
(16 Dec 1997)
atomic mass unit <chemistry> One-twelfth the mass of a neutral atom of the most abundant isotope of carbon.
(16 Dec 1997)
bilateral adrenal mass <radiology> Acute granulomatous disease (e.g., TB), metastases (bilateral in 15%), pheochromocytoma (bilateral in 10%), adrenal hyperplasia (adenoma), spontaneous adrenal haemorrhage
(12 Dec 1998)
body mass index One of the anthropometric measures of body mass; it has the highest correlation with skinfold thickness or body density.
(12 Dec 1998)
breast mass <oncology, surgery> A breast lump may be benign or cancerous.
Examples of breast lumps include: breast abscess, fat necrosis, fibroadenoma, fibrocystic breast disease and breast cancer. A breast biopsy is the best way to determine the aetiology of a breast lump. Remember, 80 to 85% of all biopsies are benign.
(27 Sep 1997)
para-sellar mass <radiology> Mnemonic: SATCHMO, S sphenoid sinus tumour, A aneurysm / adenoma of pituitary, T teratoid lesion, C craniopharyngioma, H hypothalamic glioma / histiocytoma, M meningioma / metastasis, O optic glioma less common lesions: germinoma, epidermoid, hamartoma, chordoma, arachnoid cyst
(12 Dec 1998)
mass <chemistry> The quantity of matter in an object.
(09 Jan 1998)
mass-action ratio The ratio of the product of all of the product concentrations divided by the product of all of the reactant concentrations of a particular reaction; when the reaction has been completed (i.e., t = &infin;), then this ratio is equal to the equilibrium constant.
(05 Mar 2000)
mass action theory That large areas of brain tissue function as a whole in learned or intelligent action.
(05 Mar 2000)
mass action transmission <epidemiology> Transmission of infection which occurs at a rate directly proportional to the number or density of both susceptibles and infecteds present.
Some authors reserve the name mass action for transmission processes of the form b X Y/N , which we associate with STD-type transmission, and describe transmission rates of the form b X Y , as pseudo-mass action ; the two are equivalent if the population size is unchanging.
(05 Dec 1998)
mass at base of tongue <radiology> Lingual thyroid, thyroglossal duct cyst, haemangioma, other neoplasm
(12 Dec 1998)
mass attenuation coefficient <physics> The mass attenuation coefficient, u/p, of a material for uncharged ionising particles is the quotient of DN/N by pdl, where DN/N is the fraction of particles that experience interactions in traversing a distance dl in a material of density p.
(16 Dec 1997)
mass behaviour Collective behaviour of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á